Federal Register notice

Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Anti-Tumor Necrosis Factor Alpha Monoclonal Antibody Test System for Inflammatory Bowel Disease

Federal Register notice from the Federal Register

Headline as published by Federal Register: FDA on Sep 10, 2026; collected by the wire Oct 2, 2026, 7:58 PM ET.

Read at Federal Register: FDA

The Food and Drug Administration (FDA) is classifying the anti-tumor necrosis factor alpha monoclonal antibody test system for inflammatory bowel disease into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the anti-tumor necrosis factor alpha monoclonal antibody test system for inflammatory bowel disease. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of the safety and effectiveness of…

From Federal Register: FDA’s feed

Coverage

  1. Federal Register: FDA Federal Register

    Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Anti-Tumor Necrosis Factor Alpha Monoclonal Antibody Test System for Inflammatory Bowel Disease

Named in this story

Topics

Explore the named firms, organizations and MDL dockets above. Sources and method